Y. Taniguchi et al., INHIBITION BY NIMESULIDE OF PROSTAGLANDIN PRODUCTION IN RAT MACROPHAGES, Drugs under experimental and clinical research, 24(1), 1998, pp. 17-27
We have investigated the inhibitory action of nimesulide (4-nitro-2-ph
enoxymethanesulfonanilide) an release of prostaglandin E-2 (PGE(2)) fr
om rat peritoneal exudated macrophages (macrophages) and its mechanism
of action. PGE(2) release from macrophages stimulated with opsonized
zymosan (OPZ) were increased in the 20 h after stimulation, whereas no
significant increase was noted in PGE(2) release from unstimulated ma
crophages. Nimesulide caused a weak inhibition of PGE(2) release from
macrophages at 15 min after OPZ stimulation as compared with indometha
cin, but nimesulide caused approximately the same strong inhibition as
indomethacin at 10 h after OPZ stimulation. Cellular cyclooxygenase (
COX) activity in macrophages at 10 h after OPZ stimulation was increas
ed approximately seven times the COX activity in macrophages before OP
Z stimulation. Nimesulide caused approximately the same strong inhibit
ion of cellular COX activity as indomethacin at 10 h after OPZ stimula
tion. COX-1 mRNA was expressed in macrophages irrespective of OPZ stim
ulation, but COX-2 mRNA was expressed only after OPZ stimulation, and
COX-2 protein was simultaneously induced. Nimesulide affected neither
the levels of COX-1 mRNA and COX-2 mRNA at 4 h after OPZ stimulation n
or the levels of COX-2 protein at 10 h after OPZ stimulation. In contr
ast, actinomycin D caused strong inhibition of COX-2 mRNA expression a
nd protein induction. These results suggest that inhibition by nimesul
ide of PGE(2) release from macrophages, namely inflammatory cells, wou
ld be neither due to inhibition of COX-2 mRNA expression nor COX-2 ind
uction, but to the selective inhibition of COX-2 activity itself.